Li Kang Biomedical Co., Ltd. (TPEX:6242)

Market Cap	1.22B -12.8%
Revenue (ttm)	581.53M +1.4%
Net Income	82.04M +0.1%
EPS	2.56 -6.5%
Shares Out	31.81M
PE Ratio	14.94
Forward PE	n/a
Dividend	2.00 (5.22%)
Ex-Dividend Date	Jun 16, 2025

Volume	8,629
Average Volume	11,664
Open	38.20
Previous Close	38.10
Day's Range	38.20 - 38.30
52-Week Range	35.20 - 49.90
Beta	-0.08
RSI	39.10
Earnings Date	Mar 13, 2026

About Li Kang Biomedical

Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drink products. It also engages in the management and consulting of tourism factory business; and offers telemarketing services. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd. in September 2014. Li Kang Biomedical Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.

• Industry: Travel Services
• Sector: Consumer Discretionary
• Founded: 1982
• Employees: 122
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6242

Financial Performance

In 2024, Li Kang Biomedical's revenue was 565.52 million, a decrease of -10.15% compared to the previous year's 629.38 million. Earnings were 77.02 million, a decrease of -30.60%.